リップ化粧品の国際規制に重大な欠陥を確認(Experts identify gap in global lip cosmetics regulation)

ad

2026-08-05 バーミンガム大学

英国バーミンガム大学の研究チームは、口紅やリップバームなどの唇に塗布する化粧品(リップコスメ)に対する世界的な規制には重大な盲点があると指摘した。リップ製品は使用中に少量が日常的に飲み込まれるにもかかわらず、多くの国では皮膚に使用する一般的な化粧品と同じ枠組みで安全性が評価されており、経口摂取による曝露リスクが十分考慮されていない。研究では各国・地域の規制を比較した結果、摂取を前提とした評価方法や統一的な基準が欠如していることが判明した。研究者らは、PFAS(有機フッ素化合物)や可塑剤、色素など、飲み込まれる可能性のある成分については、皮膚曝露だけでなく経口曝露も含めたリスク評価を導入すべきであると提言している。今回の成果は、化粧品の安全性評価を実際の使用実態に即したものへ見直し、消費者保護を強化するための国際的な規制整備の必要性を示している。

リップ化粧品の国際規制に重大な欠陥を確認(Experts identify gap in global lip cosmetics regulation)
Lip cosmetics are being targeted towards children and teenagers – among girls aged six to eight in the US, 45% already use lipstick or lip gloss.

<関連情報>

透過性の高い唇:唇用化粧品化学物質の全身曝露に関する重要な知識ギャップ The Permeable Lip: A Critical Knowledge Gap for Systemic Exposure to Lip Cosmetic Chemicals

Iseult Lynch,L Cristiana Gheorghe,Nora Hassas,Robert G Lee,John Milligan,Laura DiGirolamo
Integrated Environmental Assessment and Management  Published:05 August 2026
DOI:https://doi.org/10.1093/inteam/vjag128

Abstract

The pervasive use of lip cosmetics results in chronic, low-dose exposure to complex mixtures of chemicals via multiple routes, yet current cosmetic safety regulations treat lip products as conventional topical applications to skin. While the EU safety assessment framework acknowledges ingestion as an exposure route for lip products, standardised lip-specific testing models do not currently exist. The US requires no mandatory pre-market safety review for cosmetic ingredients and systemic exposure consideration is confined to voluntary industry assessment (except for colour additives). In both jurisdictions, exposure estimates are based on usage data from 2005 that do not reflect current real-world usage patterns of lip cosmetics, including frequent reapplication, product layering, and marketing based on food characteristics. The unique physiology of the lips, which represent a transitional tissue between external skin and oral mucosa provides an additional exposure route: the vermilion and labial mucosa are characterized by a markedly thinner and incompletely keratinised epithelium, reduced lipid barrier components, high vascularisation, and constant moisture—collectively conferring substantially higher permeability than facial skin. Evidence from pharmacology demonstrates that oral mucosal tissues are deliberately exploited for rapid systemic drug delivery. By comparing how the oral mucosal exposure route is evaluated across cosmetic, food, and pharmaceutical regulatory regimes, this review identifies a critical regulatory gap: chemicals applied to the lips are assessed under frameworks designed for low-permeability skin, despite a biological reality more consistent with mucosal exposure. This mismatch undermines the accuracy of current risk assessments and may lead to systematic underestimation of internal dose for certain lip cosmetic ingredients including microplastics. Addressing this gap will require lip-specific exposure models, physiologically relevant in vitro systems, and updated regulatory guidance to ensure that cosmetic safety assessment accurately reflects the unique exposure profile of lip products.

医療・健康
ad
ad
Follow
ad
タイトルとURLをコピーしました